1-5 of 5
Y Maeda
Close
Sort by
Journal Articles

Phase 1 Results of the First-in-Class CXCR1/2 Inhibitor SX-682 in Patients with Hypomethylating Agent Failure Myelodysplastic Syndromes

David A. Sallman, Amy E. DeZern, Arlene A. Gayle, Stuart J. Kahn, Eric Padron, Jeffrey E. Lancet, Andrew Kuykendall, Kendra Sweet, Onyee Chan, Dean Y. Maeda, Aaron D. Schuler, John A. Zebala, Rami S. Komrokji
Journal: Blood
Blood (2022) 140 (Supplement 1): 2070–2072.
https://doi.org/10.1182/blood-2022-159774
Published: 2022
Journal Articles

Prognostic Analysis of Hodgkin Lymphoma (HL) in JAPAN

Rumiko Okamoto, K. Itoh, T. Kinoshita, T. Watanabe, K. Yoshimura, T. Chou, M. Ogura, M. Hirano, H. Asaoku, M. Kurosawa, Y. Maeda, K. Omachi, Y. Moriuchi, M. Kasai, K. Ohnishi, N. Takayama, Y. Morishima, K. Tobinai, H. Kaba, S. Yamamoto, H. Fukuda, M. Kikuchi, T. Yoshino, Y. Matsuno, T. Hotta, M. Shimoyama
Journal: Blood
Blood (2008) 112 (11): 4830.
https://doi.org/10.1182/blood.V112.11.4830.4830
Published: 2008
Journal Articles

Targeted Molecular Therapy for Inherited Glycosylphosphatidylinositol Deficiency.

A.M. Almeida, MD, Y. Murakami, PhD, A. Baker, MD, Y. Maeda, PhD, Irene Roberts, PhD, Taroh Kinoshita, PhD, D.M. Layton, MD, A. Karadimitris, PhD
Journal: Blood
Blood (2006) 108 (11): 487.
https://doi.org/10.1182/blood.V108.11.487.487
Published: 2006
Journal Articles

Different Roles of Glycosylphosphatidylinositol in Various Hematopoietic Cells as Revealed by a Mouse Model of Paroxysmal Nocturnal Hemoglobinuria

Y. Murakami, T. Kinoshita, Y. Maeda, T. Nakano, H. Kosaka, J. Takeda
Journal: Blood
Blood (1999) 94 (9): 2963–2970.
https://doi.org/10.1182/blood.V94.9.2963
Published: 1999
Journal Articles

New therapeutic effects of retinoid for adult T-cell leukemia [letter]

Y Maeda, J Miyatake, H Sono, Y Sumimoto, M Matsuda, F Horiuchi, Y Tatsumi, K Irimajiri, A Horiuchi
Journal: Blood
Blood (1996) 88 (12): 4726–4727.
https://doi.org/10.1182/blood.V88.12.4726.bloodjournal88124726
Published: 1996